Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 3,475 | 3,262 | 3,670 | 3,352 | 3,978 |
| Operating Income | -3,475 | -3,262 | -3,670 | -3,352 | -3,978 |
| Other Income | 23 | 26 | 29 | 27 | 12 |
| Pre-tax Income | -3,452 | -3,236 | -3,641 | -3,325 | -3,966 |
| Net Income Continuous | -3,452 | -3,236 | -3,641 | -3,325 | -3,966 |
| Net Income | $-3,452 | $-3,236 | $-3,641 | $-3,325 | $-3,966 |
| EPS Basic Total Ops | -0.12 | -0.12 | -0.14 | -0.13 | -0.14 |
| EPS Basic Continuous Ops | -0.13 | -0.12 | -0.14 | -0.13 | -0.15 |
| EPS Diluted Total Ops | -0.12 | -0.12 | -0.14 | -0.13 | -0.14 |
| EPS Diluted Continuous Ops | -0.13 | -0.12 | -0.14 | -0.13 | -0.15 |
| EBITDA(a) | $-3,472 | $-3,257 | $-3,664 | $-3,347 | $-3,973 |